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Abstract
Objective—To compare treatment fidelity among treatment arms in the Telephone Assessment 
and Skill-Building Kit study for stroke caregivers (TASK II) with respect to: 1) protocol 
adherence; 2) intervention dosage; and 3) nurse intervener perspectives.
Design—A randomized controlled clinical trial design.
Setting—Urban, community, midwestern United States.
Subjects—254 stroke caregivers (mean ± SD age, 54.4 ± 11.8 years), 55 (22.0%) males and 199 
(78.4%) females) randomized to the TASK II intervention (n=123) or an Information, Support, and 
Referral (ISR) comparison group (n=131).
Interventions—TASK II participants received the TASK II Resource Guide; ISR participants 
received a standard caregiver brochure. At approximately 8 weeks after discharge, both groups 
received 8 weekly calls from a nurse, with a booster call 4 weeks later.
Measures—Protocol adherence was evaluated with the TASK II Checklist for Monitoring 
Adherence. Intervention dosage was measured by the number of minutes caregivers spent reading 
materials and talking with the nurse. Nurse intervener perspectives were obtained through focus 
groups.
Results—Protocol adherence was 80% for the TASK II and 92% for the ISR. As expected, 
intervention dosage differed between TASK II and ISR with respect to caregiver time spent 
reading materials (t=−6.49; p<.001) and talking with the nurse (t=−7.38; p<.001). Focus groups 
with nurses yielded further evidence for treatment fidelity and recommendations for future trials.
Conclusions—These findings substantiate treatment fidelity in both study arms of the TASK II 
stroke caregiver intervention trial [NIH R01NR010388; ClinicalTrials.govNCT01275495].
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There is a need for greater attention to ensuring and reporting treatment fidelity in clinical 
trials.1–3 Much of the limited literature on treatment fidelity in behavioral research has 
focused on adherence in the experimental group, with less attention given to the comparison 
group.4–7 Monitoring fidelity in both groups is essential to establish treatment 
differentiation8 and to ensure treatment components are delivered as designed, thus reducing 
the risk for Type I and Type II errors.4,9
A subgroup of the National Institutes of Health (NIH), the Behavior Change Consortium 
(BCC), has developed guidelines to improve intervention adherence and protect the 
scientific rigor of behavioral research. The guidelines include a framework comprised of five 
elements: study design, personnel training, protocol delivery, participant receipt, and 
enactment.10, 11 Design ensures adequate hypothesis testing relative to the underlying theory 
and clinical processes. Training is assessed by evaluation of the research staff ability to 
deliver the intervention. Delivery is an evaluation of consistent protocol delivery. Receipt is 
an indication the protocol was received and understood by the participant. Enactment is an 
assessment of participant performance of behavioral skills or tasks outside of the study 
protocol.
Findings from recent systematic reviews of outcomes from clinical trials suggest that 
evidence for treatment fidelity is lacking.1,3 In the neuro-rehabilitation literature, although 
treatment fidelity has been recommended as a key component to intervention testing,11 a 
review of aphasia treatment studies over the last decade indicated only 14% reported such 
data.12 Among caregiver trials, only two studies offered evidence for treatment fidelity 
following the National Institutes of Health Behavior Change Consortium 
framework.7,12,14Additionally, in the few studies where treatment fidelity was reported, most 
focused on protocol adherence in the experimental group and lacked evidence for treatment 
differentiation.6–8, 15
To address this gap, researchers from the Telephone Assessment and Skill Building (TASK 
II) Intervention Study for Stroke Caregivers clinical trial used a novel approach of 
quantitative and qualitative methods to evaluate treatment fidelity following the NIH 
Behavior Change Consortium framework. In addition to comparing treatment fidelity in both 
study arms, the researchers held focus groups with the nurse interveners to determine their 
perspectives on treatment fidelity. Further information about the original TASK intervention 
[NIH K01NR008712; ClinicalTrials.gov NCT00264745]16–18 and the TASK II trial [NIH 
R01NR010388; ClinicalTrials.gov NCT01275495] has been published elsewhere.19–21 
Analyses of the primary outcomes from the TASK II trial are ongoing.
The purposes of these analyses, were to compare the TASK II (experimental) and 
Information, Support, and Referral (ISR) (comparison) groups with respect to: 1) protocol 
adherence; 2) intervention dosage (i.e., nurse call time in minutes; time spent reading study 
materials; TASK II participant call ratings); and 3) nurse intervener perspectives on 
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treatment fidelity. It was hypothesized there would be: 1) no significant differences in 
protocol adherence between the two study arms; and 2) significant differences in 
intervention dosage between the two study arms.
Methods
The primary purpose of the randomized controlled clinical trial was to determine the 
efficacy of the TASK II intervention (n=123) compared to the Information, Support, and 
Referral (ISR) (n=131) group. The study received approval from the University Institutional 
Review Board and informed consent was obtained from all participants. Caregivers were 
persons who considered themselves to be the main (non-paid) person providing most of the 
care for a stroke survivor. Caregivers were primarily family members (spouse/significant 
other, adult child, other relative or friend) and were randomly assigned to either the TASK II 
or Information Support and Referral group after baseline data was collected. Nurse 
interveners were hired and trained for either the TASK II or Information, Support, and 
Referral group. Because of the content of the telephone calls, nurses were required to have a 
registered nurses license. The trial consisted of nine nurse-led telephone calls to primary 
caregivers, beginning within 8 weeks after stroke survivors were discharged.
In the TASK II group, participants received the TASK II Resource guide, a pamphlet from 
the American Heart Association (AHA) entitled, “Caring for Stroke Survivors,”22 and calls 
from trained nurses who taught caregivers how to: a) assess their needs for providing care 
for the stroke survivor, b) assess their personal needs as a result of caregiving, and c) 
empower caregivers to independently address current and future needs using innovative 
skill-building strategies.16, 17 The TASK II Resource guide was the intervention toolkit that 
contained tips sheets and skill-building activities designed for stroke family caregivers and 
addressed commonly encountered caregiver needs and concerns. If randomized to the 
Information, Support, and Referral group, stroke caregivers were mailed an information 
packet about the study, the same AHA brochure22 and received calls from trained study 
nurses who used therapeutic communication techniques including active listening and 
referral to the brochure or their physician for additional resources or information.
Methods used to enhance and monitor treatment fidelity included the use of detailed training 
manuals and podcasts, training booster sessions, audio and video recordings and reviews, 
centralized access to intervention recordings, quality checklists, and frequent team 
meetings.4, 11,14,23 Specific details about the integration of the five elements from the 
Behavior Change Consortium can be found in Table 1.
Adherence to the protocol was assessed by members of the research team and study 
investigators using a 27-item Checklist for Monitoring Adherence created specifically to 
address the unique components of the TASK II study. See Table 2 for items addressed on the 
checklist. Items applicable to the Information, Support, and Referral group were selected, 
following recommended procedures,9, 10 to assess adherence (13-items; 1–4, 18–25, 27). All 
nurse intervener calls to stroke caregivers were audio-recorded. Adherence was monitored 
by self-evaluation (interveners) and compared with study investigator evaluations of audio-
recorded calls at six to eight week intervals. Interveners listened to their audio-recordings 
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after the call to complete the self-evaluations. Allowing the interveners to self-evaluate their 
own calls prior to meeting with the study investigator enhanced the training process. 
Deviations from protocol, identified through negative responses on the adherence checklist, 
were addressed by additional training and monitoring.
Upon study completion, additional recorded calls were evaluated by one of the most 
experienced study intervention nurses to ensure a representative subset was evaluated in this 
analysis (i.e. inclusion of all nine calls, all interveners, and participants from early, middle, 
and later study time periods), and to ensure an adequate sample size for this study. In each 
group the adherence checklist reports, prospective and retrospective, purposively sampled, 
underwent ongoing analyses until an adequate sample size was reached. Adequacy was 
determined based on consistency in adherence ratings. Adherence on the checklist was 
scored with dichotomous (Y/N) responses for presence or absence of each item. Frequencies 
and percentages were calculated for each item. Two-way Chi-square tests of independence 
were calculated for applicable items to compare group differences.
The amount of time nurse interveners spent on the weekly calls was recorded upon 
completion of each call. Intervention dosage was calculated for nurse call duration (minutes) 
and time caregivers spent reading study materials (minutes) for the prior week. Study 
materials for the TASK II group were the TASK II Resource Guide and the American Heart 
Association (AHA) brochure.22 For the Information, Support, and Referral group it was the 
same brochure. Descriptive statistics were used to analyze duration of calls and time spent 
reading materials. Independent-samples t-tests were conducted to compare mean differences 
between the TASK II and Information, Support, and Referral groups on each of the nine 
calls (duration, time with materials) and total time. Additionally, participants in the TASK II 
group were asked to rate each call on the amount of information received (BCC framework 
“receipt”) as 1=too little; 2=just right; 3=too much. They were also asked to rate each call 
for data such as “usefulness of information used” (BCC framework “enactment”) as 1=not 
used; 2=little; 3=some; 4=a lot. Additional assessment questions with respective rating 
scales can be found in Table 4.
As a retrospective review of treatment fidelity, the nurse interveners participated in two 
focus groups with the investigators, one for the TASK II interveners and another for the 
Information, Support, and Referral interveners. Nurses recounted their experiences with the 
design, training, delivery, receipt, and enactment phases of the TASK II or Information, 
Support, and Referral intervention. Suggestions for improvement in treatment fidelity 
methods were also discussed. Results were transcribed, verified by a second researcher, and 
placed in an Excel spreadsheet. The spreadsheet was distributed to each nurse, who 
independently identified descriptive phrases (subcategories) under the categories of design, 
training, delivery, receipt, and enactment following methods for descriptive content 
analyses.24, 25 At a follow up meeting with each group, results were compared and discussed 
until agreement was reached.
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Results
A total of five nurse interveners completed 858 TASK II calls to the 123 caregivers 
randomized to the TASK II intervention. A total of four nurse interveners completed 1013 
calls to the 131 caregivers randomized to the Information, Support, and Referral 
intervention.
Protocol adherence
Detailed results of protocol adherence for each of the checklist items for both study arms can 
be found in Table 2. Overall within group (TASKII) adherence to the checklist was 80% 
(range=28%–100%). Overall within group (Information, Support, and Referral) adherence to 
the checklist was 92% (R=63%–100%). Results for comparing percentages for adherence 
across both groups for shared items on the checklist for the TASK II and Information, 
Support, and Referral groups were 90% and 92%, respectively. Results of the chi-squared 
tests to examine the relationships between each of applicable items on the checklist 
demonstrated no significant differences between the TASK II and Information, Support, and 
Referral groups (p<.05).
Intervention dosage
A full description of the analyses for protocol dosage can be found in Table 3. Results of the 
independent samples t-tests indicated total mean scores from the two groups were 
significantly different (t=−7.38; p<.001). Mean scores between groups, for time spent on 
each call, were also significantly different for each weekly call, when analyzed individually. 
Results of the independent samples t-tests demonstrated total mean scores for the two groups 
on time spent reading materials were significantly different (t=−6.49; p<.001). Mean scores 
between groups were also significantly different for time spent reading materials at each 
weekly call, when analyzed individually.
Detailed results for participants randomized to the TASKII group on calls 1–9 overall 
evaluation ratings for receipt and enactment can be found in Table 4. The average across all 
nine calls for the amount of information (receipt) was “just right” (96%). Overall, 61% rated 
the call information as used (enactment) “some” or “a lot.” On average, most caregivers 
found the TASK II intervention to be useful, found strategies to be moderately helpful, and 
most made progress on resolving problems (Table 4).
Focus groups
The categories and subcategories derived for the two groups are depicted in Figure 1.
Representative quotes for each of the subcategories can be found in the supplementary Table 
found online.
For the TASK II nurse intervener group, there were 112 qualitative descriptions of the 
nurses’ experiences coded into subcategories based on the five NIH Behavior Care 
Consortium categories of design, training, delivery, receipt, and enactment. For the 
Information, Support, and Referral nurse intervener group, there were a total of 60 
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descriptive phrases coded similarly. Their comments provided a general evaluation of both 
the TASK II and ISR interventions.
Design—When asking nurses about their perception of the design component of treatment 
fidelity, they responded with comments about the TASK II Resource Guide. Several nurses 
thought it was well-designed and valuable for the caregivers and made several suggestions 
for improvements that included reorganization of the materials, addressing content gaps, 
addressing flexibility to allow for more tailoring to individual needs. Nurses noted that 
educational level of the nurse did not matter as much as quality of communication skills and 
the ability to follow the caregiver’s lead. The Information, Support, and Referral nurses 
reported the AHA brochure was helpful but needed additional information about financial 
issues. The weekly calls were generally acceptable as scheduled but some nurses suggested 
greater flexibility in the timing of the calls. Information, Support, and Referral nurses 
thought their experience was helpful in using effective communication skills, active listening 
techniques, and being able to pick up on clues provided by the caregivers. They offered 
suggestions for future design modifications to include instructions to address concerns for 
basic needs and safety and also documenting call summaries.
Training—The TASK II nurses suggested training improvements in these areas: : 1) 
knowledge of how to differentiate between stress and depression, so as to not overemphasize 
depressive symptoms; 2) listening to actual calls with experienced TASK II nurses; and 3) 
including audio-taped calls as exemplars for how to handle specific difficult situations 
(suicidal, depressed, overly talkative). They also expressed the need for more training on the 
skill-building tip sheets. The Information, Support, and Referral nurse interveners noted that 
active listening was particularly challenging “I felt extremely uncomfortable…and with 
repeated practice was able to overcome the teaching role.” A nurse said she was reassured 
that sometimes “conversations would be short and it’s okay, it was helpful to get that 
information that they [caregivers] may have more or less to talk about.”
Delivery—Nurses thought communicating with caregivers was an important aspect of the 
intervention. The skill-building tip sheets were considered to be key features of the TASK II 
Resource Guide. Weekly team meetings were considered integral to effective delivery of the 
TASK II intervention for learning and support. With respect to telephone delivery, they 
agreed that delivering the TASK II intervention by telephone was “quite feasible.” The 
caregiver needs assessment was important yet challenging, particularly on subsequent calls 
when they were asked to assess helpfulness of the previous call. One of the nurses offered 
the following as a suggested way to begin each call: “First I’m going to ask you about how 
our conversation went last week, then I’m going to ask you about this week, then I’m going 
to ask about future needs and concerns.” Information, Support, and Referral group nurses 
discussed the importance of using effective communication including establishing rapport, 
using opening statements, and asking open-ended questions. Study nurses expressed 
difficulty with the protocol restrictions in offering advice, education, and other information 
not found in the AHA brochure. The importance of documenting the content of the calls was 
also discussed. For example, “if I went back and looked at my notes, I could find out what to 
follow up on.”
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Receipt—The TASK II nurses offered suggestions for using Resource Guide for the 
weekly calls. For example, a nurse said “[for a person] to sit and read the TASK II Resource 
Guide, there is no emotion… but to have it delivered by a nurse… have that investment in 
them, nurses were the hope in the kit.” Differences in caregiver education level, life 
experiences, and motivation levels were thought to influence caregiver receipt. The nurses 
agreed they had to “adapt their teaching style for each of those situations to make it work.” 
Information, Support, and Referral nurse interveners, reported that most caregivers thought 
the AHA brochure was helpful and cited the topics of reflex crying, depression, and signs of 
a stroke as discussed frequently. The nurses also noted variations in caregiver responses to 
the AHA brochure, primarily related to reading ability and educational levels.
Enactment—TASK II nurses reported the process of asking about the use and number of 
minutes spent reading study materials was “cumbersome.” They also noted examples of 
caregiver use of study information such as using the tip sheet about how to talk with health 
care professionals. The Information, Support, and Referral nurses reported caregivers used 
information from the AHA brochure such as taking time for themselves, attending an 
aphasia support group, and feeling more at ease about what to do when specific issues arose.
Discussion
These findings provide evidence for treatment fidelity in the TASK II stroke caregiver 
intervention trial. As expected, there were no differences across the two study arms when 
comparing protocol adherence, supporting minimal protocol drift. Also as expected, there 
were significant differences protocol dosage in call duration and time spent reading study 
materials between the TASK II and Information, Support, and Referral groups. Finally, focus 
groups with nurse interveners demonstrated evidence for treatment fidelity following the 
NIH Behavior Change Consortium in the areas of design, training, delivery, receipt, and 
enactment. They also offered suggestions for improvements that will be used in future trials.
Protocol adherence
For the TASK II group, there was a high level of overall adherence to the protocol. For items 
in which adherence rates were noted to be lower than 60%, the investigators noted 
opportunities for improvement with the nurse and provided retraining and re-evaluation. In 
addition, a general discussion of the item was held in the weekly team meetings for the 
benefit of all the intervention nurses. For example, in reference to item 11, when stress was 
present, the protocol led the nurse to assess for depressive symptoms and other emotions 
using skill-building tip sheets. Addressing the level of stress for each problem led some 
caregivers to believe that they should be experiencing more stress, and resulted in some 
nurses overemphasizing depressive symptoms and other negative emotions. During the early 
team meetings and protocol updates, this problem was discussed and the protocol was 
modified so that depressive symptoms were not always assessed in caregivers who were 
stressed, particularly if depressive symptoms had been assessed during prior calls. 
Eliminating the repeated assessments and discussions of stress and depression levels within 
the skill building tip sheets did not detract from the design of the protocol; nor did the nurses 
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ignore symptoms, and the alteration allowed the nurses to deliver the intervention in a less 
mechanistic manner when stress or depressive symptoms were not predominant.
Decisions to alter delivery methods such as stress and depression assessments were 
purposeful and data based operational decisions. Beck and colleagues26 suggested that 
tailored interventions may have greater efficacy than standardized interventions, thus 
resulting in greater adherence, improved outcomes, and cost savings. With evidence-based 
decisions, the context of a behavioral intervention (training, format, setting, patient 
population or evaluations) can be modified without actually altering the content or 
effectiveness of the intervention.27
Adherence rates for items 14 through 17 were low because they were always addressed 
towards the end of the phone call and there was often not enough time for further skill-
building. In addition, if they had been covered in an earlier call, the nurse did not always 
address them again, a factor that may have affected the lower rates for these items.
Item 7 on the checklist required the caregiver to assess amount of help needed with all tip 
sheets of interest and had an adherence rate of 28%. Following a discussion in the weekly 
meetings, it was approved for the caregiver to select the tip sheet of highest interest or need 
rather than to rate the amount of help needed for each tip sheet of interest, and this created 
an artificially lower adherence.
In the Information, Support, and Referral group, there were no individual items less than 
60%. The only item at 63% adherence was item 25 “thanking the participant.” Some of the 
nurses reported that they often did thank the participant after the recording was turned off at 
the very end of the conversation and may have been missed. This item, and other protocol 
recommendations, was also addressed at weekly team meetings as a reminder, included in 
the protocol update tracking sheet, and made available via electronic file format for all study 
team members to access and review. The use of ongoing “protocol updates” electronic 
tracking files during weekly team meetings greatly enhanced momentum, augmented 
training, and helped maintain treatment fidelity. The files provided documentation on issues 
that were discussed during the weekly team meetings for both the TASK II and Information, 
Support, and Referral nurses. The TASK II and Information, Support, and Referral protocol 
updates were referenced regularly and provided an enhanced orientation to new nurses that 
were hired later during course of the study. While the initial protocols contained detailed 
procedures, the protocol updates helped nurses “put these procedures into action” with 
actual caregivers. Putting the procedures into action is consistent with recommendations for 
implementation strategies that advocate for operationalizing interventions within the 
framework of the actor [nurse], action [TASK II or Information, Support, and Referral 
intervention], action targets [caregivers] and dose implementation outcomes [delivery of 
content as intended].28 The protocol updates also documented what was modified, type of 
modification, and nature of the content changes in a tailored intervention.27
Finally, these findings suggest there were no differences in protocol adherence as assessed 
by the Checklist for Monitoring Adherence when comparing the TASK II intervention group 
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nurses to the Information, Support, and Referral intervention group nurses. This contributes 
evidence to support minimal protocol drift within and across study arms over time.
Protocol dosage
As expected, there were significant differences in call duration and time spent reading study 
materials between the TASK II and Information, Support, and Referral groups. The TASK II 
calls took longer, and caregivers spent more time reading the TASK II Resource Guide than 
the AHA pamphlet. There was a surprising amount of variability in the duration of the calls 
for both groups that can be attributed to individual variability among the participants as 
evidenced by some of the wide standard deviations found in Table 4. The amount of time 
spent reading study materials also varied widely within and between groups with the 
Information, Support, and Referral group spending much less time reading the AHA 
brochure compared to the much larger and more in-depth TASK II Resource Guide.
Focus groups
No studies were found in the literature to document the qualitative experiences of nurses 
while delivering behavioral interventions. The NIH Behavior Change Consortium 
framework was embedded a priori into the study design to ensure study nurses were naïve to 
the concept of treatment fidelity until the study was completed. By doing so, strengths, 
weaknesses, and opportunities for future research design and delivery were identified in the 
focus groups. Findings demonstrated consistent support of the treatment fidelity framework. 
The nurses provided valuable feedback on the design of the TASK II and Information, 
Support, and Referral interventions for future implementation that will be used to guide 
future implementation of the TASK II Intervention for Stroke Caregivers.
Nurses offered suggestions for future training to include listening to experienced nurses 
deliver the intervention rather than practicing with a fellow novice nurse. They noted with 
surprise their ability to deliver the protocols completely by telephone and believed telephone 
delivery sharpened their listening skills. These findings were consistent with those of 
Pettinari and Jessopp29 who stated that “your ears become your eyes” in a telephonic 
intervention. The nurses listened intently to nonvisual cues to effectively build rapport and 
tailor their interactions with caregivers, similar to interveners in Pettinari and Jessopp’s 
study29 who developed different skills to “compensate for the absence of visibility.”
Qualitative comments from the TASK II nurses during the focus group revealed additional 
considerations for intervention delivery. For example, the needs assessment process was 
challenging. Nurses initially had trouble finding time to cover the skill-building tip sheets, 
but learned to create time after gaining a greater understanding that providing information 
alone (i.e. content tip sheets) often results in little to no impact on caregiver outcomes; 
whereas, studies that use information combined with skill building strategies (e.g., problem 
solving) are much more effective.30,31 In the Information, Support, and Referral nurse 
group, communication skills including active listening was a priority. Validating caregivers’ 
emotions and “just being there” for them was considered important. During the three years 
of the intervention phase of the protocol, the weekly team meetings greatly enhanced team 
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member’s camaraderie and study engagement, and, as a result, they felt they were better able 
to implement the protocol.
The TASK II nurses suggested strategies to enhance the treatment fidelity components of 
receipt and enactment such as: (a) adapting their teaching style based on certain caregiver 
characteristics (e.g., education); (b) providing a summarization at the end of each call; and 
(c) pointing out skill-building tip sheets when caregivers mentioned strategies that they were 
using. The Information, Support, and Referral nurses suggested offering options for 
caregivers with limited reading ability and reinforcing information in the AHA brochure that 
was particularly helpful to the caregivers.
The use of the NIH Behavior Change Consortium framework for behavioral intervention 
research to address the areas of design, training, delivery, receipt, and enactment has been 
recommended.2, 4,9,10 This framework, as adapted by Resnick and colleagues,32 provided a 
replicable and reliable context for the TASK II Intervention for Stroke Caregivers. In this 
paper, we employed a novel and comprehensive approach to assessing treatment fidelity in 
both the experimental (TASK II) and Information, Support, and Referral comparison groups 
with respect to: 1) protocol adherence; 2) protocol dosage; and 3) nurse interveners’ 
perspectives regarding treatment fidelity. These findings are unique because they fill a gap in 
the literature about the importance of monitoring, comparing, and reporting treatment 
fidelity in both study arms of a stroke caregiver behavioral trial. With the known tendency to 
drift from a defined intervention in behavioral research, these findings offer novel strategies 
to evaluate treatment fidelity by comparing protocol adherence and dosage in the study arms 
that may be applicable for the design of future behavioral intervention research studies
Limitations
Although adherence to protocol was carefully monitored and assessed in this clinical trial, 
when implemented in a real world setting adherence may vary, thus potentially limiting the 
intervention effects. Regarding protocol dosage, participant reports of time spent reading 
study materials were self-reported, thus there may have been error from over- or under-
reporting. Regarding outcomes from the focus groups, there may have been personal biases 
expressed by nurse participants about their experiences as study nurses.
Clinical Messages
The maintenance of protocol adherence among each study arm is a key component of 
intervention testing in clinical trials. Monitoring and reporting of treatment fidelity is 
important to substantiate study outcomes prior to implementation in a real-world setting.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Results from focus groups with TASKII and Information, Support, and Referral nurse 
interveners
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Table 4
TASK II intervention group (N=123) evaluation of nurse calls
Mean (SD) Median (range) % per response category
Receipt
Amount of information 1.99 (.21) 2.0 (1–3) 2.5% too little (1)
95.7% just right (2)
1.8% too much (3)
Enactment
Usefulness of information 2.73 (.96) 3.0 (1–4) 12.2% not used (1)
27.2 used it a little (2)
36.3 used it some (3)
24.3% used it a lot (4)
Strategies tried 2.65 (1.01) 3.0 (1–4) 12.0% didn’t try strategies (1)
23.9% tried a little (2)
36.5% tried some (3)
22.6% tried a lot (4)
Helpfulness of strategies 3.188 (1.04) 3.0 (1–5) 7.1% no help (1)
17.1% little help (2)
33.5% moderately helpful (3)
34.7% very helpful (4)
7.6% extremely helpful (5)
Were problems resolved 1.992 (.49) 2.0 (1–4) 11.6% not resolved (1)
78.6% making progress (2)
8.8% fully resolved (3)
1.0% resolved on own (4)
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